国际外科学杂志
國際外科學雜誌
국제외과학잡지
INTERNATIONAL JOURNAL OF SURGERY
2011年
3期
199-202
,共4页
乳腺癌%多西他赛%长春瑞滨%化疗
乳腺癌%多西他賽%長春瑞濱%化療
유선암%다서타새%장춘서빈%화료
Breast cancer%Docetaxel%Vinorelbine%Chemotherapy
多西他赛和长春瑞滨均为植物碱类抗肿瘤药物,广泛用于乳腺癌治疗中,有较高的抗肿瘤活性及可耐受的毒性反应.因其独特的作用机制,多西他赛、长春瑞滨联合应用逐渐引起重视,现综述多西他赛联合长春瑞滨在乳腺癌治疗中的应用.
多西他賽和長春瑞濱均為植物堿類抗腫瘤藥物,廣汎用于乳腺癌治療中,有較高的抗腫瘤活性及可耐受的毒性反應.因其獨特的作用機製,多西他賽、長春瑞濱聯閤應用逐漸引起重視,現綜述多西他賽聯閤長春瑞濱在乳腺癌治療中的應用.
다서타새화장춘서빈균위식물감류항종류약물,엄범용우유선암치료중,유교고적항종류활성급가내수적독성반응.인기독특적작용궤제,다서타새、장춘서빈연합응용축점인기중시,현종술다서타새연합장춘서빈재유선암치료중적응용.
Docetaxel and vinorelbine, which were plant alkaloids, had showed the good activities as chemotherapy of breast cancer. Combination chemotherapy with docetaxel and vinorelbine had drawn more and more attention. This papers reviewed the docetaxel/vinorelbine combination treatment of breast cancer.
